Curta

Curta exists to help healthcare technology companies demonstrate the clinical and economic value of their products so that patients can gain access to meaningful treatments. The firm generates strategic evidence for biopharma and medical-technology clients across the product lifecycle, combining health economics and outcomes research with quantitative analysis, economic modeling, real-world evidence, evidence synthesis, health technology assessment strategy, and value communications. Its work helps clients understand how evidence affects reimbursement, coverage, policy, and commercial decisions in the United States and international markets.

Led by experts with more than 30 years of industry experience, Curta is a fully partner-owned research organization. Senior partners oversee engagements alongside multidisciplinary teams of health economists, clinicians, statisticians, modelers, data scientists, and research associates. Curta has developed economic models, payer tools, oncology simulation models, and Executive AI, a secure generative-AI assistant that enables users to interact with completed reports and other deliverables. Founded in 2018 and merged with VeriTech in 2022, Curta supports small biotechnology companies through large global biopharma organizations.